Tectonic Therapeutic, Inc. Stockholders Equity

Quick Answer

Tectonic Therapeutic, Inc. reported Stockholders Equity of $251.33 million for fiscal year 2025.

Tectonic Therapeutic, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $251.33M +78.5%
2024 $140.78M +266.3%
2023 -$84.64M -85.4%
2022 -$45.65M -126.9%
2021 $169.48M -33.4%
2020 $254.34M +36.7%
2019 $186.01M +52.2%
2018 $122.18M +628.1%
2017 -$23.14M -405.2%
2016 -$4.58M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $267.53M +77.9% -5.7%
June 30, 2025 $283.77M +70.6% -5.7%
March 31, 2025 $301.04M +402.3% +113.8%
December 31, 2024 $140.78M +266.3% -6.4%
September 30, 2024 $150.36M +288.5% -9.6%
June 30, 2024 $166.37M +337.7% +267.1%
March 31, 2024 -$99.57M -66.4% -17.6%
December 31, 2023 -$84.64M -85.4% -6.1%
  • Tectonic Therapeutic, Inc. showed an increase of +78.5% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2016–2025 period, Tectonic Therapeutic, Inc.’s stockholders equity has grown by 5588.7% (from -$4.58 million to $251.33 million).
  • The most recent figure is from Tectonic Therapeutic, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment